The Current Ratio as of December 2025 (TTM) for We Can Medicines Co., Ltd. (6929.TWO) is 1.58

According to We Can Medicines Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 1.58. This represents a change of -1.30% compared to the average of 1.60 of the last 4 quarters.

We Can Medicines Co., Ltd. (6929.TWO) Historical Current Ratio (quarterly & annually)

How has 6929.TWO Current Ratio performed in the past?

The mean historical Current Ratio of We Can Medicines Co., Ltd. over the last ten years is 1.39. The current 1.58 Current Ratio has changed 11.25% with respect to the historical average. Over the past ten years (40 quarters), 6929.TWO's Current Ratio was at its highest in in the September 2024 quarter at 1.63. The Current Ratio was at its lowest in in the March 2023 quarter at 0.

We Can Medicines Co., Ltd. (6929.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of We Can Medicines Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

We Can Medicines Co., Ltd. (6929.TWO) Average Current Ratio

How has 6929.TWO Current Ratio performed in the past?

The current Current Ratio of We Can Medicines Co., Ltd. (6929.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

We Can Medicines Co., Ltd. (6929.TWO) Current Ratio vs. Peers

How is 6929.TWO’s Current Ratio compared to its peers?

We Can Medicines Co., Ltd.’s Current Ratio is less than Far East Bio-Tec Co., Ltd. (4.53), less than DaBomb Protein Biotech Corp. (3.31), less than Sino Tactful Co., Ltd. (12.97), less than Li Kang Biomedical Co., Ltd. (1.80), less than Kuangli Bio-Tech Holdings Co., Ltd. (1.64), less than Mikobeaute International Co., Ltd. (3.25), less than Jia Jie Biomedical Co., Ltd. (3.91), less than Mao Bao Inc. (2.78), greater than Grand Hall Enterprise Co., Ltd. (1.38), greater than Tittot Company Limited (1.31),

Build a custom stock screener for We Can Medicines Co., Ltd. (6929.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like We Can Medicines Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

We Can Medicines Co., Ltd. (6929.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like We Can Medicines Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.